Browse > Article

Clinical and Laboratory Features of Korean Mucopolysaccharidoses (MPSs)  

Sohn, Woo Yun (Department of Pediatrics, Samsung Medical Center,Sungkyunkwan University School of Medicine)
Lee, Jee Hyun (Department of Pediatrics, Samsung Medical Center,Sungkyunkwan University School of Medicine)
Paik, Kyung Hoon (Department of Pediatrics, Samsung Medical Center,Sungkyunkwan University School of Medicine)
Kwon, Eun Kyoung (Department of Pediatrics, Samsung Medical Center,Sungkyunkwan University School of Medicine)
Kim, Ahn Hee (Department of Pediatrics, Samsung Medical Center,Sungkyunkwan University School of Medicine)
Jin, Dong Kyu (Department of Pediatrics, Samsung Medical Center,Sungkyunkwan University School of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.48, no.10, 2005 , pp. 1132-1138 More about this Journal
Abstract
Purpose : The mucopolysaccharidoses (MPSs) are a heterogeneous group of lysosomal storage disorders. They are caused by a deficiency of the enzymes involved in the degradation of glycosaminoglycans. Early recognition is important because recombinant enzyme replacement therapy is now available for MPS. We studied the clinical characteristics of 80 MPS children with the object of determining the epidemiological, clinical and radiological features in Korean MPS children. Methods : Diagnosis of MPS was confirmed by skin fibroblast enzyme analysis in 80 patients between February 1995 and December 2004. Charts were retrospectively reviewed for clinical and radiological findings, as well as for intelligence and speech evaluations. Results : Hunter syndrome (MPS type II) was the most prevalent type, appearing in 51/80 cases (64 %), followed by Sanfilippo syndrome (MPS III-18%), Hurler syndrome (MPS I-15%), and Morquio syndrome (MPS IV-4%). The average age at diagnosis was 5.5 years (range 1 to 20), and the male-to-female ratio was 4.7 : 1. Typical radiographic changes were observed in 45/54 cases (83%). Mitral regurgitation was the most common cardiac defect. Moderate to profound mental retardation and hearing loss were present in 14/35 cases (56%) and 33/38 cases (82%), respectively. Four MPS II patients had bone marrow transplantation, with mixed outcomes. Five MPS I patients are currently on enzyme replacement therapy. Conclusion : Our study showed a high proportion of MPS II cases (64%), which may represent population variability. By studying the clinical features of these patients, we hope to alert pediatricians of the warning signs of MPS.
Keywords
Mucopolysaccharidoses; Clinical; Laboratory; Incidence; Korea;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Lowry RB, Applegarth DA, Toone JR, MacDonald E, Thunem NY. An update on the frequency of mucopolysaccharide syndromes in British Columbia. Hum Genet 1990;85:389-90
2 Schaap T, Bach G. Incidence of mucopolysaccharidoses in Israel : Is Hunter disease a 'Jewish disease'? Hum Genet 1980;56:221-3   DOI   PUBMED
3 Muenzer J. The mucopolysaccharidoses : a heterogeneous group of disorders with variable pediatric presentations. J Pediatr 2004;144(5 Suppl):27S-34S   DOI   PUBMED   ScienceOn
4 Peters C, Balthazor M, Shapiro EG, King RJ, Kollman C, Hegland JD, et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996;87:4894-902
5 Guffon N, Souillet G, Maire I, Straczek J, Guibaud P. Follow up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 1998;133:119-25   DOI   ScienceOn
6 Vellodi A, Young E, Cooper A, Lidchi V, Winchester B, Wraith JE. Long term follow-up following bone marrow transplantation for Hunter disease. J Inherit Metab Dis 1999;22:638-648   DOI   ScienceOn
7 Young ID, Haper PS. The natural history of the severe form of Hunter's syndrome : a study based on 52 cases. Dev Child Neurol 1983;25:481-9
8 Vellodi A, Young EP, Cooper A, Wraith JE, Winchester B, Meany C, et al. Bone marrow transplantation for mucopolysaccharidosis type I : experience of two British centers. Arch Dis Child 1997;76:92-9   DOI   ScienceOn
9 Colville GA, Bax MA. Early presentation in the mucopolysaccharide disorders. Chil Care Health Dev 1996;22:31-6   DOI   ScienceOn
10 Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, et al. Enzyme replacement therapy for mucopolysaccharidosis I : a randomized, double blinded, placebo-cotrolled, multinational study of recombinanat human alpha-L-laronidase. J Pediatr 2004;144:581-8   DOI   ScienceOn
11 Field RE, Buchanan JA, Copplemans MG, Aichroth PM. Bone marrow transplantation in Hurler's syndrome. Effect on skeletal development. J Bone Joint Surg (Br) 1994;76:975-81
12 Nelson J, Crowhurst J, Carey B, Greed L. Incidence of the Mucopolysaccharidoses in Western Australia. Am J Med Genet 2003;123:310-3
13 Muenzer J. Mucopolysacharidoses. Adv Pediatr 1986;269-302
14 Herskhovitz E, Young E, Rainer J, Hall CM, Lidchi V, Chong K, et al. Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS IV) : long term follow up. J Inherit Metab Dis 1999;22:50-62   DOI   ScienceOn
15 Clarke L, Muenzer J, Klodny EH, Pastores G, Beck M, Wraith JE. RhIDU enzyme replacement therapy for MPS I : 24 week extension study. Am J Hum Genet 2002;71(Suppl):481
16 Neufeld EF, Muenzer J. The mucopolysaccharidoses. In : Scriver CR, Beudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. 8th ed. New York : McGraw Hill, 2001:3421-52
17 Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M, et al. Enzyme replacement therapy in mucopolysaccharidosis I. N Engl J Med 2001;344:182-8   DOI   ScienceOn
18 Weisstein JS, Delgado E, Steinbach LS, Hart K, Packman S. Musculoskeletal manifestations of Hurler syndrome : Long term follow-up after bone marrow transplantation. J Pediatr Orthop 2004;24:97-101   DOI   ScienceOn
19 Nelson J. Incidence of the mucopolysacharides in Northern Ireland. Hum Genet 1997;101:355-8   DOI   PUBMED   ScienceOn
20 Kurihara M, Kumagai K, Goto K, Imai M, Yagishita S. Severe type Hunter's syndrome. Polysomnographic and neuropathological study. Neuropediatrics 1992;23:248-56   DOI